ArticleCancers2023

Efficacy of Immune Checkpoint Inhibitor (ICI) Rechallenge in Advanced Melanoma Patients' Responders to a First Course of ICI: A Multicenter National Retrospective Study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée, GCC).

Charlée Nardin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.